Year 2011 Vol. 19 No 1

PAEDIATRIC SURGERY

ADAMASHVILI G.G., DGEBUADZE M.A., SHVANGIRADZE E.V., KORINTELI I.A.

PLASMAPHERESIS EFFICACY IN TREATMENT OF SURGICAL SEPSIS AND MULTIPLE ORGAN INSUFFICIENCY

Objectives. To evaluate the therapeutic efficacy of plasmapheresis in treatment of surgical sepsis and multiple organ insufficiency.
Methods. 26 patients 012 years of age (newborns, infants, 37 and 712 years of age), admitted to Tbilisi State Medical University Pediatric Hospital in 20012005 with surgical sepsis and multiple organ insufficiency were investigated. The patients were randomized into two groups: patients, who receive plasmapheresis in addition to the conventional treatment and patients, who receive standard sepsis treatment only.
Results. Plasmapheresis obstacles the progression of the organ dysfunction in patients of all investigated age groups with surgical sepsis and its application permits to decrease patients mortality.
Conclusions. Plasmapheresis is an effective and safe addition to the conventional treatment of surgical sepsis in children.

Keywords: treatment of surgical sepsis, multiple organ insufficiency, plasmapheresis
p. 68 71 of the original issue
References
  1. Zeni, F. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment / F. Zeni, B. Freeman, C. Natanson // Crit. Care Med. 1997. Vol. 25, N 7. P. 1095-1100.
  2. The increasing burden of severe sepsis in US children / R. S. Watson [et al.] // Crit. Care Med. 2001. Vol. 29, N 12. P. A8.
  3. Bone, R. C. Sir Isaac Newton, sepsis, SIRS, and CARS / R. C. Bone // Crit. Care Med. 1996. Vol. 24, N 7. P. 1125-1128.
  4. 4.Opal, S. M. Clinical trials for severe sepsis. Past failures, and future hopes / S. M. Opal, A. S. Cross // Inf. Dis. Clin. N. Am. 1999. Vol. 13, N 2. P. 285-297.
  5. Continuous plasmafiltration in sepsis syndrome / J. H. Reeves [et al.] // Crit Care Med. 1999. Vol. 27, N 10. P. 2096-2104.
  6. Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial / S. John [et al.] // Nephrol. Dial Transplant. 2001. Vol. 16, N 2. P. 320-327.
  7. A phase II randomized, controlled trial of continuous hemofiltration in sepsis / L. Cole [et al.] // Crit. Care Med. 2002. Vol. 30, N 1. P. 100-106.
  8. A pilot study of coupled plasma filtration with adsorption in septic shock / C. Ronco [et al.] // Crit. Care Med. 2002. Vol. 30, N 6. P. 1250-1255.
  9. Hjorth, V. Plasmapheresis as part of the treatment for septic shock / V Hjorth, G. Stenlund // Scand. J. Infect. Dis. 2000. Vol. 32, N 5. P. 511-514.
  10. Stegmayr, B. G. The presence of superantigens and complex host responses in severe sepsis may need a broad therapeutic approach / B. G. Stegmayr // Therapeutic. Apheresis. 2001. Vol. 5, N 2. P. 111-114.
  11. Stegmayr, B. G. Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome / B. G. Stegmayr // Therapeutic. Apheresis. 2001. Vol. 5, N 2. P. 123-127.
  12. Current topics on cytokin removal technologies / K. Matsuda [et al.] // Therapeutic. Apheresis. 2001. Vol. 5, N 4. P. 306-314.
  13. Nakae, H. Cytokine removal by plasma exchange with continuous hemodiaflitration in crtitically ill patients / H. Nakae, Y. Asanuma, K. Tajimi // Therapeutic. Apheresis. 2002. Vol. 6, N 6. P. 419-424.
  14. Endotoxin and cytokin removal in sepsis / C. Tella [et al.] // Therapeutic. Apheresis. 2002. Vol. 6, N 2. P. 109-115.
  15. On the use of liquid stored or crioprecipitate-poor plasma inplasma exchange / B. Stegmayr [et al.] // Immune and Metabolic Aspects of Therapeutic Blood Purification Systems / L. C. Smeby, S. Jorstad, T. E. Wideroe. Basel: Karger, 1986. P. 117-121.
  16. Microvascular thrombosis in pediatric multiple organ failure: is it a therapeutic target? / T. Nguyen [et al.] // Pediatr. Crit. Care Med. 2001. Vol. 2, N 3. P. 187-196.
  17. Biochemical and pathologic evidence of thrombotic microangiopathy in children with thrombocytopenia associated multiple organ failure / T. Nguyen [et al.] // Crit. Care Med. 2001. Vol. 29, N 12. P. A10.
  18. The tissue factor and plasminogen activator inhibitor type 1 response in pediatric sepsis induced multiple organ failure / J. Green[et al.] // Thromb. Haemost. 2002. Vol. 87, N 2. P. 218-23.
  19. Venkataraman, R. Clinical review: Extracorporeal blood purification in severe sepsis / R. Venkataraman, S. Subramanian, J. A. Kellum // Crit. Care. 2003. Vol. 7, N 2. P. 139-145.
  20. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock / R. P. Dellinger [et al.] // Intensive Care Med. 2004. Vol. 30, N 4. P. 536-555.
  21. , . . / . . . .: , 2000. 432 .
  22. Development of a pediatric multiple organ dysfunction score: use of two strategies / S. Leteurtre [et al.] // Med. Decis Making . 1999. Vol. 19, N 4. P. 399-410.
Contacts | ©Vitebsk State Medical University, 2007-2023